Evidence map›Paper›PMID 18522853›Full record

ArticleCell stem cell2008

High-throughput screening assay for the identification of compounds regulating self-renewal and differentiation in human embryonic stem cells.

Sabrina C Desbordes, Dimitris G Placantonakis, Anthony Ciro, Nicholas D Socci, Gabsang Lee, Hakim Djaballah, Lorenz Studer

Open access · bronzeAbstract read
In one paragraph

Article in Cell stem cell, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 219 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Down-regulation of ATF1 leads to early neuroectoderm differentiation of human embryonic stem cells by increasing the expression level of SOX2.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Stem cells technology: a powerful tool behind new brain treatments.Drug delivery and translational research · 2018
    Review
  14. Teratogen screening with human pluripotent stem cells.Integrative biology : quantitative biosciences from nano to macro · 2018
    Review
  15. Article
  16. Chronic lung disease, lung regeneration and future therapeutic strategies.Chronic diseases and translational medicine · 2018
    Article
  17. Article
  18. High content analysis in amyotrophic lateral sclerosis.Molecular and cellular neurosciences · 2017
    Review
  19. Article
  20. Article

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sabrina C DesbordesDevelopmental Biology Program, Department of Neurosurgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. sabrina.desbordes@crg.es
Dimitris G Placantonakis
Anthony Ciro
Nicholas D Socci
Gabsang Lee
Hakim Djaballah
Lorenz Studer
Memorial Sloan Kettering Cancer Center · US

Funding

Therapeutic Cloning in Parkinsonian MiceR21NS044231 · NINDS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI STUDER, LORENZ P. · 2002 to 2003
$352k
HTS Screen-Neural Differentiation in Human ES Cells(RMI)R21NS053655 · NINDS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI STUDER, LORENZ P. · 2005 to 2005
$209k
NINDS NIH HHS R21 NS044231NINDS NIH HHS R21 NS053655NINDS NIH HHS R21NS44231
6 · The paper itself

Abstract

High-throughput screening (HTS) of chemical libraries has become a critical tool in basic biology and drug discovery. However, its implementation and the adaptation of high-content assays to human embryonic stem cells (hESCs) have been hampered by multiple technical challenges. Here we present a strategy to adapt hESCs to HTS conditions, resulting in an assay suitable for the discovery of small molecules that drive hESC self-renewal or differentiation. Use of this new assay has led to the identification of several marketed drugs and natural compounds promoting short-term hESC maintenance and compounds directing early lineage choice during differentiation. Global gene expression analysis upon drug treatment defines known and novel pathways correlated to hESC self-renewal and differentiation. Our results demonstrate feasibility of hESC-based HTS and enhance the repertoire of chemical compounds for manipulating hESC fate. The availability of high-content assays should accelerate progress in basic and translational hESC biology.

Indexed as

Biological AssayEmbryo ResearchAnimalsCell DifferentiationDose-Response Relationship, DrugDrug DesignDrug Evaluation, PreclinicalEmbryonic Stem CellsHumansMiceMicroarray AnalysisRegenerationResearch DesignSmall Molecule LibrariesSmall Molecule Libraries

Identifiers

PMID18522853
PMCPMC2756729
OpenAlexW1994219607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.